Quest Laboratories is engaged in the business of manufacturing of pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. These formulations fall under the trademark ‘Quest Laboratories’. The company produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC)

Quest Laboratories major competitors are Syschem (India), Bafna Pharma, Bal Pharma, Panchsheel Organics, IndoAmerican Advance, Krebs Biochem.&Inds, Kimia Biosciences.
Market Cap of Quest Laboratories is ₹186 Crs.
While the median market cap of its peers are ₹178 Crs.

Quest Laboratories seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.